首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Characterization of Micro-RNA Changes during the Progression of Type 2 Diabetes in Zucker Diabetic Fatty Rats
【2h】

Characterization of Micro-RNA Changes during the Progression of Type 2 Diabetes in Zucker Diabetic Fatty Rats

机译:Zucker糖尿病肥胖大鼠2型糖尿病进展过程中微RNA变化的特征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of the present pilot study was the identification of micro-RNA changes over time during the development and progression of type 2 diabetes (T2D) in Zucker diabetic fatty rats (ZDF rats). T2D is a complex metabolic disorder that is characterized, inter alia, by progressive failure of pancreatic β cells to produce insulin, but also by functional or morphological modifications of others organ, such as liver, adipose tissue and the cardiovascular system. Micro-RNAs are a novel class of biomarkers that have the potential to represent biomarkers of disease progression. In this study, the onset and progression of diabetes was followed in ZDF rats from six weeks until 17 weeks of age. After an initial phase of hyperinsulinemia, the animals developed T2D and lost the capacity to produce sufficient insulin. Circulating miRNAs were measured from plasma samples at four time points: pre-diabetes (six weeks of age), hyperinsulinemia (eight weeks), β cell failure (11 weeks) and late-stage diabetes (17 weeks) using TaqMan miRNA arrays. Bioinformatic analysis revealed distinct changes of circulating miRNAs over time. Several miRNAs were found to be increased over the course of the disease progression, such as miR-122, miR-133, miR-210 and miR-375. The most significantly decreased miRNAs were miR-140, miR-151-3p, miR-185, miR-203, miR-434-3p and miR-450a. Some of the miRNAs have also been identified in type 2 diabetic patients recently and, therefore, may have the potential to be useful biomarkers for the disease progression of T2D and/or the treatment response for anti-diabetic medications.
机译:本试验研究的目的是鉴定Zucker糖尿病脂肪大鼠(ZDF大鼠)的2型糖尿病(T2D)发生和发展过程中微小RNA的变化。 T2D是一种复杂的代谢紊乱,其特征尤其在于胰腺β细胞无法产生胰岛素,而且还具有其他器官如肝脏,脂肪组织和心血管系统的功能或形态学改变。微小RNA是一类新型的生物标志物,具有代表疾病进展的生物标志物的潜力。在这项研究中,从6周龄到17周龄的ZDF大鼠追踪糖尿病的发生和进展。在高胰岛素血症的初始阶段之后,这些动物发展为T2D并丧失了产生足够胰岛素的能力。使用TaqMan miRNA阵列在四个时间点从血浆样品中测量循环miRNA:糖尿病前(6周龄),高胰岛素血症(8周),β细胞衰竭(11周)和晚期糖尿病(17周)。生物信息学分析揭示了循环miRNA随时间的明显变化。发现几种miRNA在疾病进展过程中增加,例如miR-122,miR-133,miR-210和miR-375。减少幅度最大的miRNA是miR-140,miR-151-3p,miR-185,miR-203,miR-434-3p和miR-450a。最近在2型糖尿病患者中也发现了一些miRNA,因此可能具有成为T2D疾病进展和/或抗糖尿病药物治疗反应的有用生物标志物的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号